ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
15 Jul 2020

Notice of Extra General Meeting in Acarix AB

Notice of Extra General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereb...
Continue reading
author-avatar acarix
Press
August 6, 2024
15 Jul 2020

Acarix decides on a guaranteed rights issue of approximately SEK 56 million

Press release Malmö, Sweden July 15, 2020 Acarix decides on a guaranteed rights issue of approximately SEK 56 million The board of di...
Continue reading
author-avatar acarix
Press
August 6, 2024
15 Jul 2020

Acarix beslutar om garanterad företrädesemission om cirka 56 MSEK

Pressmeddelande Malmö, Sverige, 15 juli 2020 Acarix beslutar om garanterad företrädesemission om cirka 56 MSEK Styrelsen i Acarix AB ...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 May 2020

Announcement from Acarix’s annual general meeting

Press release Malmö, May 14, 2020 Announcement from Acarix's annual general meeting The annual general meeting 2020 ("AGM&#...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 May 2020

Kommuniké från årsstämman i Acarix

Press release Malmö, maj 14, 2020 Kommuniké från årsstämman i Acarix Årsstämman 2020 i Acarix AB ("Acarix" eller "Bol...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 May 2020

Acarix AB (publ) publicerar delårsrapport, januari – mars 2020

Press release (MAR) Malmö, 14 maj, 2020 Acarix AB (publ) publicerar delårsrapport, januari – mars 2020 Fortsatt fokus på strategiska...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 May 2020

Acarix AB (publ) publishes Interim Report, January – March 2020

Press release (MAR) Malmö, May 14, 2020 Acarix AB (publ) publishes Interim Report, January – March 2020 Continued focus on strategic ...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2020

Sista patienten inkluderad i den undersökande hjärtsviktstudien SEISMO

Pressmeddelande Malmö, Sverige, 11 maj 2020 Sista patienten inkluderad i den undersökande hjärtsviktstudien SEISMO Acarix AB (pub...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2020

Last patient included in Acarix’s exploratory heart failure study SEISMO

Press releaseMalmö, Sweden May 11, 2020 Last patient included in Acarix’s exploratory heart failure study SEISMO Acarix AB (publ) t...
Continue reading
author-avatar acarix
Press
August 6, 2024
23 Apr 2020

Acarix publicerar årsredovisningen för 2019

Pressmeddelande Malmö, 23 april, 2020 Acarix publicerar årsredovisningen för 2019 Idag, torsdagen den 23 april, publicerar Acarix sin...
Continue reading
author-avatar acarix
Press
August 6, 2024
23 Apr 2020

Acarix publishes the annual report for 2019

Press release Malmö, April 23, 2020 Acarix publishes the annual report for 2019 Today, Thursday April 23, Acarix is publishing its An...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Apr 2020

Notice of Annual General Meeting in Acarix AB

Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are here...
Continue reading
  • «
  • ‹
  • 25
  • 26
  • 27
  • 28
  • 29
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.